$7.45
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
Amneal Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Amneal Pharmaceuticals using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
AMRX | Amneal Pharmaceuticals | $0.19 | $0.14 | — | — | $599.05M | $663.56M | — | — | 08/09/2024 | Get Alert |
AMRX | Amneal Pharmaceuticals | — | $0.09 | $0.14 | 55.56% | — | $619.03M | $659.19M | 6.49% | 05/03/2024 | Get Alert |
AMRX | Amneal Pharmaceuticals | — | $0.09 | $0.14 | 55.56% | — | $634.23M | $616.98M | -2.72% | 03/01/2024 | Get Alert |
AMRX | Amneal Pharmaceuticals | — | $0.13 | $0.19 | 46.15% | — | $595.27M | $620.04M | 4.16% | 11/07/2023 | Get Alert |
AMRX | Amneal Pharmaceuticals | — | $0.10 | $0.19 | 90.00% | — | $562.49M | $599.05M | 6.50% | 08/04/2023 | Get Alert |
AMRX | Amneal Pharmaceuticals | — | $0.10 | $0.12 | 20.00% | — | $537.31M | $557.54M | 3.77% | 05/05/2023 | Get Alert |
AMRX | Amneal Pharmaceuticals | — | $0.21 | $0.23 | 9.52% | — | $579.91M | $609.76M | 5.15% | 03/02/2023 | Get Alert |
AMRX | Amneal Pharmaceuticals | — | $0.18 | $0.14 | -22.22% | — | $564.15M | $545.56M | -3.30% | 11/04/2022 | Get Alert |
AMRX | Amneal Pharmaceuticals | — | $0.20 | $0.19 | -5.00% | — | $536.34M | $559.36M | 4.29% | 08/05/2022 | Get Alert |
AMRX | Amneal Pharmaceuticals | — | $0.13 | $0.12 | -7.69% | — | $503.97M | $497.63M | -1.26% | 05/04/2022 | Get Alert |
AMRX | Amneal Pharmaceuticals | — | $0.20 | $0.18 | -10.00% | — | $537.35M | $536.90M | -0.08% | 03/02/2022 | Get Alert |
AMRX | Amneal Pharmaceuticals | — | $0.20 | $0.21 | 5.00% | — | $545.06M | $528.59M | -3.02% | 11/03/2021 | Get Alert |
AMRX | Amneal Pharmaceuticals | — | $0.19 | $0.25 | 31.58% | — | $523.25M | $535.08M | 2.26% | 08/09/2021 | Get Alert |
AMRX | Amneal Pharmaceuticals | — | $0.18 | $0.20 | 11.11% | — | $515.34M | $493.11M | -4.31% | 05/07/2021 | Get Alert |
AMRX | Amneal Pharmaceuticals | — | $0.13 | $0.14 | 7.69% | — | $507.02M | $510.03M | 0.59% | 02/26/2021 | Get Alert |
AMRX | Amneal Pharmaceuticals | — | $0.12 | $0.16 | 33.33% | — | $482.11M | $519.29M | 7.71% | 11/06/2020 | Get Alert |
AMRX | Amneal Pharmaceuticals | — | $0.10 | $0.13 | 30.00% | — | $458.44M | $464.66M | 1.36% | 08/06/2020 | Get Alert |
AMRX | Amneal Pharmaceuticals | — | $0.09 | $0.20 | 122.22% | — | $444.23M | $498.53M | 12.22% | 05/11/2020 | Get Alert |
AMRX | Amneal Pharmaceuticals | — | $0.05 | $0.08 | 60.00% | — | $394.78M | $397.33M | 0.65% | 02/26/2020 | Get Alert |
AMRX | Amneal Pharmaceuticals | — | $0.14 | $0.04 | -71.43% | — | $410.98M | $378.28M | -7.96% | 11/06/2019 | Get Alert |
AMRX | Amneal Pharmaceuticals | — | $0.14 | $0.09 | -35.71% | — | $428.58M | $404.64M | -5.59% | 08/05/2019 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-03 | $0.14 | $0.09 | 55.6 % |
Dec 2023 | 2024-03-01 | $0.14 | $0.09 | 55.6 % |
Sep 2023 | 2023-11-07 | $0.19 | $0.13 | 46.2 % |
Jun 2023 | 2023-08-04 | $0.19 | $0.10 | 90.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-03 | $659.19M | $619.03M | 6.49 % |
Dec 2023 | 2024-03-01 | $616.98M | $634.23M | -2.72 % |
Sep 2023 | 2023-11-07 | $620.04M | $595.27M | 4.16 % |
Jun 2023 | 2023-08-04 | $599.05M | $562.49M | 6.50 % |
Amneal Pharmaceuticals (AMRX) is scheduled to report earnings on August 9, 2024. The last reported earnings were for reported on May 3, 2024 for Q1.
The Actual EPS was $0.14, which beat the estimate of $0.09.
The Actual Revenue was $659.2M, which beat the estimate of $619M.
Browse earnings estimates, EPS, and revenue on all stocks.